Variability in microRNA recovery from plasma: Comparison of five commercial kits

Analytical Biochemistry

Volumn 488, Issue , 2015, Pages 28-35

  Brunet Vega, Anna ^a,b   Pericay, Carles ^a   Quílez, María Elisa ^a,b   Ramírez Lázaro, María José ^a,c   Calvet, Xavier ^a,c   Lario, Sergio ^a,b,c  

^a HOSPITAL DE SABADELL   (Spain)

^b Servicio de Oncología Médica   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Biomarker; Circulating microRNAs; Spike ins; Variability

Indexed keywords

BIOMARKERS; BLOOD; DIAGNOSIS; DISEASES; EFFICIENCY; POLYMERASE CHAIN REACTION; QUALITY CONTROL;

BIOLOGICAL FLUIDS; COLORECTAL CANCER; EXTRACTION METHOD; MICRORNAS; MOLECULAR DIAGNOSTICS; REVERSE TRANSCRIPTION; TECHNICAL FACTORS; VARIABILITY;

RNA;

COMPLEMENTARY DNA; MICRORNA; MICRORNA 103; MICRORNA 124; MICRORNA 18A; MICRORNA 191; MICRORNA 21; MICRORNA 23A; MICRORNA 29A; MICRORNA 30C; MICRORNA 451; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; DIAGNOSTIC KIT;

AMPLICON; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLORECTAL CANCER; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DIRECT ZOL RNA MINIPREP; DNA SYNTHESIS; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HEMOLYSIS; HUMAN; MICROARRAY KIT; MIRCURY RNA ISOLATION KIT; MIRNEASY SERUM PLASMA KIT; NUCLEOSPIN MIRNA PLASMA KIT; PLASMA; PLASMA SERUM CIRCULATING AND EXOSOMAL RNA PURIFICATION MINI KIT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; RNA ISOLATION; RNA PROCESSING; SPIKE; BLOOD; COLORECTAL TUMOR; DIAGNOSTIC KIT; FEMALE; GENE EXPRESSION REGULATION; ISOLATION AND PURIFICATION; MALE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SPAIN; VALIDATION STUDY;

BIOMARKERS; COLORECTAL NEOPLASMS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPAIN;

EID: 84940512194     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2015.07.018     Document Type: Article

References (30)

1. R.C. Friedman, K.K. Farh, C.B. Burge, and D.P. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res. 19 2009 92 105
2. H. Siomi, and M.C. Siomi Posttranscriptional regulation of microRNA biogenesis in animals Mol. Cell 38 2010 323 332
3. J. Krol, I. Loedige, and W. Filipowicz The widespread regulation of microRNA biogenesis, function, and decay Nat. Rev. Genet. 11 2010 597 610
4. M.A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A.K. Sood, and G.A. Calin MicroRNAs in body fluids: the mix of hormones and biomarkers, Nat. Rev. Clin. Oncol. 8 2011 467 477
5. S.S. Chim, T.K. Shing, E.C. Hung, T.Y. Leung, T.K. Lau, R.W. Chiu, and et al. Detection and characterization of placental microRNAs in maternal plasma Clin. Chem. 54 2008 482 490
6. C.H. Lawrie, S. Gal, H.M. Dunlop, B. Pushkaran, A.P. Liggins, K. Pulford, and et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma Br. J. Haematol. 141 2008 672 675
7. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, and et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res. 18 2008 997 1006
8. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, and et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. U. S. A. 105 2008 10513 10518
9. M. Hanke, K. Hoefig, H. Merz, A.C. Feller, I. Kausch, D. Jocham, and et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer Urol. Oncol. 28 2010 655 661
10. G.K. Wang, J.Q. Zhu, J.T. Zhang, Q. Li, Y. Li, J. He, and et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans, Eur. Heart J. 31 2010 659 666
11. K. Wang, S. Zhang, B. Marzolf, P. Troisch, A. Brightman, Z. Hu, and et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury Proc. Natl. Acad. Sci. U. S. A. 106 2009 4402 4407
12. M. Mraz, K. Malinova, J. Mayer, and S. Pospisilova MicroRNA isolation and stability in stored RNA samples Biochem. Biophys. Res. Commun. 390 2009 1 4
13. M.A. Cortez, and G.A. Calin MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases Expert Opin. Biol. Ther. 9 2009 703 711
14. M.P. Hunter, N. Ismail, X. Zhang, B.D. Aguda, E.J. Lee, L. Yu, and et al. Detection of microRNA expression in human peripheral blood microvesicles PLoS One 3 2008 e3694
15. J.D. Arroyo, J.R. Chevillet, E.M. Kroh, I.K. Ruf, C.C. Pritchard, D.F. Gibson, and et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc. Natl. Acad. Sci. U. S. A. 108 2011 5003 5008
16. K.C. Vickers, B.T. Palmisano, B.M. Shoucri, R.D. Shamburek, and A.T. Remaley MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat. Cell Biol. 13 2011 423 433
17. Z. Williams, I.Z. Ben-Dov, R. Elias, A. Mihailovic, M. Brown, Z. Rosenwaks, and et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations Proc. Natl. Acad. Sci. U. S. A. 110 2013 4255 4260
18. J.S. McDonald, D. Milosevic, H.V. Reddi, S.K. Grebe, and A. Algeciras-Schimnich Analysis of circulating microRNA: preanalytical and analytical challenges Clin. Chem. 57 2011 833 840
19. M.B. Kirschner, J.J. Edelman, S.C. Kao, M.P. Vallely, N. van Zandwijk, and G. Reid The impact of hemolysis on cell-free microRNA biomarkers, Front. Genet. 4 2013 94
20. C.C. Pritchard, E. Kroh, B. Wood, J.D. Arroyo, K.J. Dougherty, M.M. Miyaji, and et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies, Cancer Prev. Res. 5 2012 492 497
21. A. Turchinovich, T.R. Samatov, A.G. Tonevitsky, and B. Burwinkel Circulating miRNAs: cell-cell communication function? Front. Genet. 4 2013 119
22. A. Brunet Vega, C. Pericay, I. Moya, A. Ferrer, E. Dotor, A. Pisa, and et al. MicroRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers Oncol. Rep. 30 2013 320 326
23. M.D. Giraldez, J.J. Lozano, G. Ramirez, E. Hijona, L. Bujanda, A. Castells, and et al. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study Clin. Gastroenterol. Hepatol. 11 2013 681 688
24. C. Clancy, M.R. Joyce, and M.J. Kerin The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer Cancer Biomark. 15 2015 103 113
25. J.M. Ruijter, C. Ramakers, W.M. Hoogaars, Y. Karlen, O. Bakker, M.J.B. van den Hoff, and et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data Nucleic Acids Res. 37 2009 e45
26. R. Sanders, D.J. Mason, C.A. Foy, and J.F. Huggett Considerations for accurate gene expression measurement by reverse transcription quantitative PCR when analysing clinical samples Anal. Bioanal. Chem. 406 2014 6471 6483
27. A. Brunet-Vega, C. Pericay, M.E. Quílez, M.J. Ramírez-Lázaro, X. Calvet, and S. Lario Individual PCR Efficiency Values as Quality Control for Circulating miRNAs Data in Brief (submitted for publication) 2015
28. V.S. Nair, C.C. Pritchard, M. Tewari, and J.P. Ioannidis Design and analysis for studying microRNAs in human disease: a primer on -omic technologies, Am. J. Epidemiol. 180 2014 140 152
29. P. Mestdagh, N. Hartmann, L. Baeriswyl, D. Andreasen, N. Bernard, C. Chen, and et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study Nat. Methods 11 2014 809 815
30. -ΔΔCT method Methods 25 2001 402 408